Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

NCOA ONCOLOGY DRUG NEWSLETTER J A N U A R Y 2 0 2 4 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pirtobrutinib (Jaypirca) The FDA has approved pirtobrutinib (Jaypirca) in relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma …
Sutter Health details innovative programs designed to drive health equity at the most recent Modern Healthcare Social Determinants of Health Symposium.
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 Preparing for Your Poster Session at the ACCC 50th Annual Meeting & Cancer Center Business Summit Creating Your Poster As you develop your poster, determine which aspects of your research project are most interesting and important and consider how you can communicate that information visually. Posters are most effective when they mix …
CME/MOC/AAPA PRESENTER Melissa L. Johnson, MD Amplifying the ADC Advantage How to Fulfill the Potential of Antibody–Drug Conjugates as the Next Frontier in Precision Lung Cancer Care Activity Description Mounting evidence continues to elucidate the clinical potential of antibody–drug conjugates (ADCs) in the treatment of patients with lung cancer. ADCs are now transitioning from research …
Join us for an Official Best of San Antonio Breast Cancer Symposium® hosted in collaboration with Wisconsin Association of Hematology and Oncology (WAHO), Medical College of Wisconsin, and the University of Wisconsin Carbone Cancer Center on February 3, 2024, at the Pfister Hotel in Milwaukee. Engage in interactive sessions facilitated by the nation’s top breast cancer experts, as they unveil …
CME/MOC/AAPA PRESENTER Melissa L. Johnson, MD Amplifying the ADC Advantage How to Fulfill the Potential of Antibody–Drug Conjugates as the Next Frontier in Precision Lung Cancer Care Activity Description Mounting evidence continues to elucidate the clinical potential of antibody–drug conjugates (ADCs) in the treatment of patients with lung cancer. ADCs are now transitioning from research …
10 Steps to Success: Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia (CLL) Practice EFFECTIVE PRACTICE GUIDE Oral Oncolytic Clinical Workflow for Treatment of Patients with Chronic Lymphocytic Leukemia OTC = over the counter, Rx=prescription, ACCC FAN = Association of Community Cancer Centers Financial Advocacy Network), EMR=Electronic Medical Record Clinical …
For their final policy summit of 2023, the NCCN invited multidisciplinary stakeholders to Washington D.C. for a discussion focused on patients with cancer receiving comprehensive and equitable care.
CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.
As the use of chimeric antigen receptor (CAR) T-cell therapy continues to expand as an effective treatment for hematologic malignancies, understanding how to identify eligible patients early and implementation of an effective framework for identification can improve care coordination and better prepare community cancer programs for widespread use of CAR T-cell therapy.
SCOS ONCOLOGY DRUG NEWSLETTER D E C E M B E R 2 0 2 3 FDA APPROVALS Capivasertib (Truqap) and Fulvestrant (Faslodex) Combination The FDA granted approval to the combination of capivasertib (Truqap) and fulvestrant (Faslodex) for the treatment of adult patients with hormone receptor– positive, HER2-negative, locally advanced or metastatic breast cancer that harbors 1 or more PIK3CA, …
Rockville, MD – The Association of Community Cancer Centers (ACCC) today announced a new e-course, Implementing Shared Decision-Making in Bladder Cancer Care, as part of its resources for cancer care centers to access evidence-based health literacy principles and shared decision-making strategies to reduce disparities in bladder cancer care.
Founded in 2022, the Arkansas Association of Cancer Professionals (AACP) is a powerful community of multidisciplinary care providers involved in the treatment of patients with cancer. AACP is a state Chapter Member of the Association of Community Cancer Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology (ASCO). Members receive valuable educational content …
PowerPoint Presentation December 14, 2023 TxSCO Update Overview: Notable Updates 2 Federal • Congressional retirements • CRs without physician pay fix • Medicaid redeterminations - KFF enrollment predictions for 2024 • No Surprises Act update State • Special Session Updates • Primaries Federal Updates 3 Notable 2024 Congressional …